A Message from CEO
A message from CEO
Tamin Pharmaceutical Investment Company (TPICO) is Iran's most prominent pharmaceutical holding and the significant access provider of medicines in the country.
TPICO emerged from the entrenched body of Daroupakhsh holding as the only specialized pharmaceutical holding of the Social Security Investment Company (SSIC, so called Shasta) and over the years has achieved valuable success in fostering access to high quality medicines as well as delivering sustainable profit growth.
As we continue to face new challenges in our business environment, TPICO's culture is defined simply by a set of corporate values; profitability, transparency and dynamicity.
Our strengths are derived from our ability to leverage our most valuable assets; our expert team of elites, our monumental value chain, our extensive manufacturing/ distribution capabilities and our valiant efforts on making an impact.
In our journey to excellence, we will always be committed to achieving the satisfaction of stakeholders, including employees, shareholders, patients and society as a whole.
We hope that with the will, effort and solidarity of about 10,000 members of TPICO family, we can provide the ground for further added value creation through efficiency of the supply chain, development of assets and expanding our international business collaborations with a special focus on innovation.
As you navigate our website, we hope you learn more about the qualities that make TPICO an outstanding corporation in Iran's pharmaceutical market. Whether you are a potential customer or a business partner we look forward to finding out how we can work together to make an impact in development of healthcare.
I ultimately thank the almighty God for giving me the opportunity of serving in this strategic complex, the utmost goal of which is to alleviate the suffering of the patients and to make a healthier, more dynamic and productive society. Since there is always more to be done, we will remain fully committed to strengthening our capabilities and to further evolving TPICO going forward making a brighter future.
Dr. Pouya Farhat